Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Analog Devices | ADI | Nov 27, 2024 | 217.17 | -0.86 |
AnaptysBio | ANAB | Nov 27, 2024 | 25.12 | -0.51 |
Anavex Life Sciences | AVXL | Nov 27, 2024 | 9.03 | -0.06 |
Andretti Acquisition II | POLE | Nov 27, 2024 | 9.97 | 0.00 |
Andretti Acquisition II Unit | POLEU | Nov 27, 2024 | 10.05 | 0.00 |
Anebulo Pharmaceuticals | ANEB | Nov 27, 2024 | 1.43 | +2.14 |
ANEW Medical | WENA | Nov 27, 2024 | 0.73 | 0.00 |
Angel Oak Financial Strategies | FINS | Nov 27, 2024 | 12.73 | +0.32 |
Angel Oak Mortgage REIT | AOMR | Nov 27, 2024 | 9.62 | +0.10 |
Anghami | ANGH | Nov 27, 2024 | 0.74 | -3.07 |
Angi A | ANGI | Nov 27, 2024 | 1.90 | 0.00 |
AngioDynamics | ANGO | Nov 27, 2024 | 7.02 | +0.43 |
Anglogold Ashanti | AU | Nov 27, 2024 | 24.79 | -2.02 |
Anheuser-Busch InBev ADR | BUD | Nov 27, 2024 | 54.08 | +0.28 |
ANI Pharmaceuticals | ANIP | Nov 27, 2024 | 59.39 | +2.64 |
Anika Therapeutics | ANIK | Nov 27, 2024 | 17.72 | 0.00 |
Anixa Biosciences | ANIX | Nov 27, 2024 | 3.31 | -0.30 |
Annaly Capital Management | NLY | Nov 27, 2024 | 19.82 | +0.56 |
Annaly Capital Management F Pref | NLY-F | Nov 27, 2024 | 25.94 | -0.27 |
Annaly Capital Management G Pref | NLY-G | Nov 27, 2024 | 25.51 | -0.31 |
Annaly Capital Management I Pref | NLY-I | Nov 27, 2024 | 25.77 | -0.23 |
Annexon | ANNX | Nov 27, 2024 | 5.34 | +0.95 |
Annovis Bio | ANVS | Nov 27, 2024 | 6.54 | -0.30 |
ANSYS | ANSS | Nov 27, 2024 | 348.02 | -0.52 |
Antelope Enterprise | AEHL | Nov 27, 2024 | 0.25 | +4.43 |
Anterix | ATEX | Nov 27, 2024 | 34.81 | +5.61 |
Antero Midstream | AM | Nov 27, 2024 | 15.75 | -0.76 |
Antero Resources | AR | Nov 27, 2024 | 32.48 | -1.84 |
Anywhere Real Estate | HOUS | Nov 27, 2024 | 4.91 | -4.29 |
Aon | AON | Nov 27, 2024 | 393.31 | +0.78 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.